30 31 Mycobacterium tuberculosis (Mtb) secretes pathogenicity factors and immunologically active 32 molecules via membrane vesicles. However, nothing is known about the mechanisms involved 33 in mycobacterial vesicle biogenesis. This study investigates molecular determinants of 34 membrane vesicle production in Mtb by analyzing Mtb cells under conditions of high vesicle 35 production: iron limitation and VirR restriction. Ultrastructural analysis showed extensive cell 36 envelope restructuring in association with vesicle release that correlated with downregulation 37 of cell surface lipid biosynthesis and peptidoglycan alterations. Comparative transcriptomics 38 showed common upregulation of the iniBAC operon in association with high vesicle production 39 in Mtb cells. Vesicle production analysis demonstrated that the dynamin-like proteins (DLPs) 40 encoded by this operon, IniA and IniC, are necessary for release of EV by Mtb in culture and in 41 infected macrophages. Isoniazid, a first-line antibiotic, used in tuberculosis treatment, was 42 found to stimulate vesicle release in a DLP-dependent manner. Our results provide a new 43 understanding of the function of mycobacterial DLPs and mechanistic insights into vesicle 44 biogenesis. The findings will enable further understanding of the relevance of Mtb-derived 45 extracellular vesicles in the pathogenesis of tuberculosis and may open new avenues for 46 therapeutic research. 47 48 49 3 IMPORTANCE 50 Iron is an essential nutrient that promotes survival and growth of M. tuberculosis, the bacterium 51 that causes human tuberculosis (TB). Limited availability of iron, often encountered in the host 52 environment, stimulates M. tuberculosis to secrete membrane-bound extracellular vesicles 53 containing molecules that may help it evade the immune system. Characterizing the bacterial 54 factors and mechanisms involved in the production of mycobacterial vesicles is important for 55 envisioning ways to interfere with this process. Here, we report the discovery of proteins 56 required by M. tuberculosis for vesicle biogenesis in culture and during host cell infection. We 57 also demonstrate a connection between antibiotic response and extracellular vesicle 58 production. The work provides insights into the mechanisms underlying vesicle biogenesis in 59 M. tuberculosis and permits better understanding of the significance of vesicle production to M. 60 tuberculosis-host interactions and antibiotic stress response. 61 62 63 4 64 65 Extracellular vesicles (EV) are membrane-bound structures actively secreted by most, if not all, 66 cells and play important roles in intercellular communication. Bacteria release EV containing 67 proteins, genetic material, and lipids to communicate with both prokaryotic and eukaryotic cells 68 in their environment (1, 2).
INTRODUCTION
recently, induction of iniBAC has been linked to the biosynthesis of methyl-branched lipids, 178 (20) . While IniB is homologous to an Arabidopsis thaliana cell wall protein of unknown function, 179 iniA and iniC encode GTP-binding domain containing proteins related to dynamin-like proteins 180 (DLPs) (Fig. 3A) (21) . iniAC are necessary for efficient EV release in Mtb. 201 To investigate the role of iniBAC genes in Mtb-EV biogenesis, we assayed EV production in a 202 Mtb mutant in which iniA was replaced by a hygromycin-resistance cassette (iniA::hyg) (23). observed by dot blot analysis at the lowest concentration tested, 0.005 µg.ml -1 ( Fig 5B) .
224
Quantification of protein and lipid associated with vesicles, indicated over 2-fold increased 225 vesicle release at the highest INH concentration tested 50 ng/ml which is still 10 fold lower than Lack of DLPs abrogates vesicle-mediated iron acquisition in Mtb. 236 When faced with iron limitation, Mtb produces mycobactin and carboxymycobactin, 237 hydrophobic and amphiphilic siderophores, respectively. While carboxymycobactin is actively 238 secreted via membrane transporters (25), mycobactin is localized in close proximity to the 239 cytoplasmic membrane (26), and is exported via EV (7). Mycobactin containing EV can serve 240 as the sole Fe source for Fe deficient Mtb (7). Accordingly, culture filtrates from the EV-241 deficient iniA::hyg strain were unable to support the growth of a siderophore synthesis 242 deficient strain of Mtb (ST142) (27) while culture filtrates derived from the equivalent number of 243 WT Mtb cells were highly efficient ( Fig 7A) . This phenotype was complemented by a wild-type 244 copy of iniBAC (Fig. 7A) . Notably, the growth rate ( Fig. 7B ) and levels of mycobactin 245 synthesized by iniA::hyg and the WT Mtb in low Fe conditions were equal ( Fig 7C) , indicating that the reduced EV production in the absence of DLPs is not due to a defect in sensing and 247 responding to Fe limitation. It also indicates that iron obtained through carboxymycobactin 248 maintains normal growth of iniA::hyg in culture medium. These results suggest that by 249 abrogating EV production, the disruption of mycobacterial DLP function decreases availability 250 of a public good i.e., extracellular mycobactin and may limit acquisition of Fe in the host, 251 particularly in microenvironments where carboxymycobactin has restricted access to Fe or is 252 sequestered by the host siderophore binding protein, lipocalin (28) which is abundant in TB 253 granulomas (15).
255
Reduced release of bacteria-derived EV by iniA::hyg infected macrophages. 256 Previous studies have shown that bacteria-derived EV are released by Mtb-infected mouse 257 macrophages and can act as potent immunomodulators of uninfected cells (5, 6). To determine 258 whether Mtb cells require DLPs to produce EV in macrophages, we compared the abundance 259 of vesicles containing bacterial components released into the culture medium from THP-1 260 macrophages 24 hours after infection with different Mtb strains: WT, iniA::hyg, or iniA::hyg 261 complemented with iniBAC. Mtb derived EV were less abundant in the medium of iniA::hyg-262 infected macrophages compared to macrophages infected with WT or iniBAC-complemented 263 iniA::hyg Mtb (Fig. 8B ). This effect was not due to reduced replication of the mutant, as WT 
DISCUSSION
There is compelling evidence suggesting that EV produced by pathogenic mycobacteria 271 constitute a delivery mechanism for immunologically active molecules and bacterial factors that 
